EDWARDS LIFESCIENCES CORPORATION Funds and ETFs Edwards Lifesciences Corporation
Equities
EW
US28176E1082
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 86.1 USD | -2.31% |
|
-2.00% | +12.92% |
ETFs positioned on Edwards Lifesciences Corporation
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.20% | 1,174 M€ | +23.54% | ||
| 0.20% | 273 M€ | -.--% | ||
| 0.20% | 655 M€ | -.--% | - | |
| 0.19% | 322 M€ | +13.88% | - | |
| 0.19% | 29 M€ | -.--% | - | |
| 0.18% | 414 M€ | +14.60% | - | |
| 0.18% | 1,006 M€ | -.--% | - | |
| 0.18% | 2,567 M€ | +15.32% | - | |
| 0.17% | 1 M€ | +0.04% | ||
| 0.17% | 559 M€ | +14.30% | - | |
| 0.17% | 1,848 M€ | +18.39% | - | |
| 0.15% | 61 M€ | +24.46% | - | |
| 0.15% | 6 M€ | +17.98% | - | |
| 0.14% | 133 M€ | +8.97% | - | |
| 0.13% | 7 M€ | +0.11% | - | |
| 0.13% | 288 M€ | +22.45% | ||
| 0.12% | 205 M€ | -.--% | ||
| 0.12% | 1 M€ | -.--% | ||
| 0.12% | 35 M€ | +14.72% | - | |
| 0.12% | 206 M€ | -.--% | ||
| 0.11% | 284 M€ | -.--% | ||
| 0.11% | 23 M€ | -.--% | - | |
| 0.11% | 786 M€ | -.--% | ||
| 0.11% | 248 M€ | +11.11% | - | |
| 0.10% | 14 M€ | +16.19% | - |
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Calendar
2024-07-24
- Q2 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
86.1
USD
Average target price
96.31
USD
Spread / Average Target
+11.86%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +12.92% | 51.88B | |
| +9.55% | 222B | |
| +14.41% | 196B | |
| +24.02% | 148B | |
| +33.92% | 114B | |
| +4.94% | 65.69B | |
| +3.16% | 50.02B | |
| -4.32% | 38.81B | |
| -1.99% | 34.59B | |
| +23.04% | 31.09B |
- Stock Market
- Equities
- EW Stock
- Funds and ETFs Edwards Lifesciences Corporation
